Giant-Cell Tumor Treatment: Curettage Without Denosumab Is Better
Denosumab is an FDA-approved drug for osteoporosis. It works by binding RANKL, thus inhibiting osteoclastic activity. Denosumab has also been …
In Spinal-Metastasis Surgery, High-Volume Yields Better Outcomes
In orthopaedics, the connection between a hospital/surgeon performing a surgical procedure many times and improved outcomes has been demonstrated compellingly …
Aggressive Treatment Improves QOL in Many Cases of Spinal Metastases
A significant portion of metastatic disease comes with no clear identification of a primary tumor; this is unfortunately the case …
Faster Relief for Patients with Painful Bone Metastases
A technique that combines magnetic resonance (MR) imaging with high-intensity focused ultrasound hyperthermia provides faster pain relief than conventional radiation …
JBJS Editor’s Choice—VTE Risk with Metastatic Skeletal Lesions: Fix Prophylactically or Not?
In the February 15, 2017 issue of The Journal, Aneja et al. utilize a large administrative database to …
JBJS Case Connector Debuts Whole-Slide Images
It is not often that readers of scholarly journals have a “Wow!” moment, a chance to be unexpectedly delighted by …